<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Reprod Biol Endocrinol</journal-id><journal-title>Reproductive Biology and Endocrinology : RB&#x00026;E</journal-title><issn pub-type="epub">1477-7827</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1477-7827-7-56</article-id><article-id pub-id-type="pmid">19493328</article-id><article-id pub-id-type="doi">10.1186/1477-7827-7-56</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Identification of ER&#x003b2;1 and ER&#x003b2;2 in human seminoma, in embryonal carcinoma and in their adjacent intratubular germ cell neoplasia</article-title></title-group><contrib-group><contrib id="A1" contrib-type="author"><name><surname>Rago</surname><given-names>Vittoria</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>vittoriarago@yahoo.co</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Romeo</surname><given-names>Francesco</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>francesromeo@libero.it</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Giordano</surname><given-names>Francesca</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>docfrancy@yahoo.it</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Ferraro</surname><given-names>Aurora</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>aurfer@virgilio.it</email></contrib><contrib id="A5" contrib-type="author"><name><surname>And&#x000f2;</surname><given-names>Sebastiano</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>sebastiano.ando@unical.it</email></contrib><contrib id="A6" corresp="yes" contrib-type="author"><name><surname>Carpino</surname><given-names>Amalia</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>am_carpino@yahoo.it</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Cell Biology, Faculty of Pharmacy, University of Calabria, Cosenza, Italy</aff><aff id="I2"><label>2</label>Pathologic Anatomy Unit, Annunziata Hospital, Cosenza, Italy</aff><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>3</day><month>6</month><year>2009</year></pub-date><volume>7</volume><fpage>56</fpage><lpage>56</lpage><ext-link ext-link-type="uri" xlink:href="http://www.rbej.com/content/7/1/56"/><history><date date-type="received"><day>19</day><month>1</month><year>2009</year></date><date date-type="accepted"><day>3</day><month>6</month><year>2009</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2009 Rago et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2009</copyright-year><copyright-holder>Rago et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author> Rago Vittoria vittoriarago@yahoo.co </dc:author><dc:title> Identification of ER&#x003b2;1 and ER&#x003b2;2 in human seminoma, in embryonal carcinoma and in their adjacent intratubular germ cell neoplasia </dc:title><dc:date>2009</dc:date><dcterms:bibliographicCitation>Reproductive Biology and Endocrinology 7(1): 56-. (2009)</dcterms:bibliographicCitation><dc:identifier type="sici">1477-7827(2009)7:1&#x0003c;56&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1477-7827</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p>Estrogens exert a role on germ cell physiology of normal human testis through the mediation of the estrogen receptor (ER) beta subtypes. Epidemiological studies evidenced an increased incidence of testicular germ cell cancer after elevated pre-natal estrogen exposure but the expression of estrogen receptors in these testicular neoplasms has not been well elucidated.</p></sec><sec sec-type="methods"><title>Methods</title><p>Immunohistochemistry and Western blot analysis were used to investigate the expression of three distinct ER isoforms, ERalpha, ERbeta1, and ERbeta2 in paraffin-embedded tissues from seminomas and embryonal carcinomas, which are the most common testicular germ cell tumours.</p></sec><sec><title>Results</title><p>Neoplastic cells of all specimens revealed a positive ERbeta1 and ERbeta2 immunoreactivity, while the ERalpha signal was undetectable. A similar pattern of estrogen receptor immunostaining was also observed in the malignant germ cells of intratubular germ cell neoplasia, adjacent to testicular cancers. Western blot analysis of tumour extracts revealed two immunoreactive bands, a 59 kDa band for ERbeta1 and a 53 kDa band for ERbeta2.</p></sec><sec><title>Conclusion</title><p>A variable ERbeta expression was previously reported in testicular germ cell tumours and, particularly, an ERbeta down-regulation was evidenced in seminoma and embryonal carcinoma. Conversely, the current study has clearly identified ERbeta1 and ERbeta2 in the neoplastic cells of seminoma and embryonal carcinoma, as well as in the malignant cells of their common pre-invasive precursor, intratubular germ cell neoplasia. Therefore, our findings suggest that ERbeta1, together with a possible ERbeta2 contribute, can mediate estrogen action in both early and late neoplastic testicular germ cells, not confirming the previously hypothesized antiproliferative effect of ERbeta on male gonadal cells.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>A current worldwide rise in the incidence of testicular germ cell cancer has been evidenced by epidemiological studies [<xref ref-type="bibr" rid="B1">1</xref>]. However, despite of growing researches on pathogenesis of these testicular neoplasms, lots of gaps of knowledge remain on molecular mechanisms responsible for the tumorigenesis process [<xref ref-type="bibr" rid="B2">2</xref>].</p><p>An increased rate of testicular germ cell tumours, after prenatal estrogen exposure, has supported the hypothesis that these hormones could play a role in the male gonadal carcinogenesis in combination with genetic susceptibility [<xref ref-type="bibr" rid="B3">3</xref>-<xref ref-type="bibr" rid="B6">6</xref>]. On the other hand, the recognized ability of estrogens to regulate cell growth and apoptosis [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>] could be involved in testicular neoplastic proliferation.</p><p>Estrogens exert their pleiotropic and tissue-specific effects through the differential expression of distinct estrogen receptors, ER&#x003b1; and ER&#x003b2;, and their coregulators [<xref ref-type="bibr" rid="B9">9</xref>].</p><p>In normal human testis, estrogen receptor-&#x003b2; is known as the mediator of physiological estrogen action. Testicular somatic and germ cells express mainly the two isoforms ER&#x003b2;1 and ER&#x003b2;2 [<xref ref-type="bibr" rid="B10">10</xref>-<xref ref-type="bibr" rid="B12">12</xref>]. ER&#x003b2;1 is the full length wild type ER&#x003b2; and the only fully functional isoform [<xref ref-type="bibr" rid="B13">13</xref>] while ER&#x003b2;2 is a splice variant, lacking aminoacid essential for binding estradiol [<xref ref-type="bibr" rid="B14">14</xref>]. Mediation of estrogen signalling is determined by differential dimerization of ERs and a recent study indicated that ER&#x003b2;2 can heterodimerize with ER&#x003b2;1 and enhance its transactivation in a ligand-dependent manner [<xref ref-type="bibr" rid="B13">13</xref>]. However, the distinct biological roles of the ER&#x003b2; isoforms is still undefined [<xref ref-type="bibr" rid="B15">15</xref>].</p><p>In testicular germ cell tumours the expression of estrogen receptors has not been still clarified. In fact, a highly variable ER&#x003b2; expression has been reported in the different tumour types [<xref ref-type="bibr" rid="B16">16</xref>].</p><p>Therefore, with the aim to expand the ER knowledge in male gonadal neoplasms, the present work investigated the expression of three distinct ER isoforms (ER&#x003b1;, ER&#x003b2;<sub>1 </sub>and ER&#x003b2;<sub>2</sub>) in testicular tissues from patients with seminoma and embryonal carcinoma, which are the most common cancers in young men.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Patients</title><p>The investigation has been performed on formalin-fixed and paraffin-embedded testis tissues from 16 male patients (ages 20 &#x02013; 35 years) with pure seminoma (n = 10) and pure embryonal carcinoma (n = 5) undergoing to therapeutic orchidectomy. Control testicular tissues were obtained from 2 male patients (ages 29 and 35 years) showing testes with a like-Sarcoidosis granulomatous lesion. The archival cases were provided by the Pathologic Anatomy Unit (Annunziata Hospital, Cosenza, Italy). The ethical committee members of the University of Calabria approved the investigation programme.</p></sec><sec><title>Histopathological analysis</title><p>Morphological studies were carried out by Haematoxylin-Eosin staining. Testis tumour samples were also investigated by placental-like alkaline phosphatase (PLAP) immunohistochemistry, using the anti- human PLAP as primary antibody (30 minutes at RT) followed by the avidin-biotin-horseradish peroxidase complex (ABC/HRP) and diaminobenzidine visualization.</p><sec><title>Chemicals</title><p>The reagents were purchased from Sigma Aldrich (Milan, Italy), unless otherwise indicated.</p></sec></sec><sec><title>Antibodies</title><p>Anti-ER&#x003b1; primary antibody was mouse monoclonal F-10 (Santa Cruz Biotechnology, California, USA) which recognizes epitope mapping at the C-terminus region of the human native ER&#x003b1;. Anti-ER&#x003b2; primary antibody was rabbit polyclonal H150 (Santa Cruz Biotechnology, California, USA) which recognizes epitope mapping at the N-terminus regions of human native ER&#x003b2;. Anti-ER&#x003b2;1 primary antibody was mouse monoclonal MCA1974S (Serotec, Oxford, UK) which recognizes epitope mapping at the C-terminus regions of human native ER&#x003b2;1 while anti-ER&#x003b2;2 primary antibody was mouse monoclonal MCA2279S (Serotec, Oxford, UK) which recognizes epitope mapping at the C-terminus regions of human native ER&#x003b2;2. Anti human PLAP antibody was monoclonal mouse, clone 8A9, (DAKO-Cytomation, Milan, Italy). Rabbit polyclonal anti &#x003b2;-actin (Santa Cruz Biotechnology, California, USA) was also used as loading control. Biotinylated goat-anti-mouse IgG (Vector Laboratories, INC, Burlingame, California, USA), goat anti-rabbit horseradish peroxidase conjugated IgG (Amersham, USA) and goat anti-mouse horseradish peroxidase conjugated IgG (Amersham, USA) were used as secondary antibodies.</p></sec><sec><title>Immunohistochemical analysis</title><p>Paraffin embedded sections, 5 &#x003bc;m thick, were mounted on slides precoated with poly-lysine, and then they were deparafinized and dehydrated (7&#x02013;8 serial sections). Immunohistochemical experiments were performed after heat-mediated antigen retrieval in 0.01 M citrate buffer, pH 6. Hydrogen peroxide (3% in distillate water) was used, for 30 minutes, to inhibit endogenous peroxidase activity while normal goat serum (10%) was utilised, for 30 minutes, to block the non-specific binding sites.</p><p>Immunodetection was carried out using anti-ER&#x003b1; (1:50), anti-ER&#x003b2;1 and anti-ER&#x003b2;2 (1:100) primary antibodies at 4&#x000b0;C overnight. Then, a biotinylated goat-anti-mouse IgG was applied (1:600) for 1 hour at RT, followed by the avidin-biotin-horseradish peroxidase complex (ABC/HRP) (Vector, Laboratories, CA, USA). Immunoreactivity was visualized by using the diaminobenzidine chromogen (DAB)(Zymed Laboratories, CA, USA). Testis sections were also counterstained with haematoxylin. The primary antibody was replaced by normal rabbit serum in negative control sections. Absorption controls have utilised primary antibodies preabsorbed with an excess (5 nmol/ml) of the purified respective blocking peptides (Santa Cruz Biotechnology, Ca, USA), at 4&#x000b0;C for 48 hours. Breast cancer tissue was used as positive control for ER&#x003b1;, while control human testis was used as positive control for both ER&#x003b2;1 and ER&#x003b2;2. Six-seven serial sections were processed for each sample.</p></sec><sec><title>Scoring system</title><p>The immunostained slides were examined by light microscopy using the "Allred Score" [<xref ref-type="bibr" rid="B17">17</xref>], which combines a proportion score and an intensity score. A proportion score was assigned representing the estimated proportion of positively stained tumour cells (0 = none; 1 = &#x0003c;1/100; 2 = 1/100 to &#x0003c;1/10; 3 = 1/10 to &#x0003c;1/3; 4 = 1/3 to 2/3; 5 = &#x0003e;2/3). An intensity score was assigned by the average estimated intensity of staining in positive cells (0 = none; 1 = weak; 2 = moderate; 3 = strong). Proportion score and intensity score were added to obtained a total score that ranged from 0 to 8. A minimum of 100 cells were evaluated in each slide. Six-seven serial sections were scored for each sample. The one-way ANOVA was used to evaluate the differences in the scores between tumoral and control samples.</p></sec><sec><title>Protein extraction</title><p>Protein extraction from formalin-fixed paraffin-embedded sections has been carried out according to Ikeda [<xref ref-type="bibr" rid="B18">18</xref>]. Briefly, 50 &#x003bc;m testis sections were deparaffinized in xylene, dehydrated in graded ethanol, immersed in distilled water, and air dried. Then, the neoplastic area was recovered from the glass slides, further it was cut into small pieces and placed in Eppendorf tubes. Two hundred &#x003bc;l of RIPA buffer, pH 7,6 (1 M NaH<sub>2</sub>PO<sub>4</sub>, 10 mM Na<sub>2</sub>HPO<sub>4</sub>, 154 mM NaCl, 1% Triton X-100, 12 mM C<sub>24</sub>H<sub>39</sub>O<sub>4</sub>Na, 0,2% NaN<sub>3</sub>, 0,95 mM NaF, 2 mM PMSF, 50 mg/ml aprotinin, 50 mM leupeptin) containing 0,2% SDS, was added to each tube and the contents were incubated at 100&#x000b0;C for 20 minutes, followed by incubation at 60&#x000b0;C for 2 hours. After incubation, tissue lysates were centrifuged at 15,000 &#x000d7; g for 20 minutes at 4&#x000b0;C and the supernatants were stored at -80&#x000b0;C until biochemical analysis.</p></sec><sec><title>Western blot analysis</title><p>Tissue lysates were quantified using Bradford protein assay reagent [<xref ref-type="bibr" rid="B19">19</xref>]. Equal amounts of protein (50 &#x003bc;g) were boiled for 5 minutes, separated under denaturing conditions by SDS-PAGE on 10% polyacrylamide Tris-glycine gels and electroblotted to nitrocellulose membrane. Non-specific sites were blocked with 5% non fat dry milk in 0.2% Tween-20 in Tris-buffered saline (TBS-T) for 1 hour at room temperature and incubated overnight with anti-ER&#x003b1;(F-10) (1:500), anti-ER&#x003b2;(H150) (1:500), anti-actin (1:1000) primary antibodies. The antigen-antibody complexes were then detected by incubation of the membranes for 1 hour at 22&#x000b0;C with the horseradish peroxidase-conjugated secondary antibodies (1:7000). The bound secondary antibodies were located with the ECL Plus Western blotting detection system (Amersham, USA) according to the manufacturer's instruction. Each membrane was exposed to the film for 2 minutes.</p><p>Protein extracts from cultured MCF7 (breast cancer cell line) and LnCap (prostate cancer cell line) cells were used as positive controls for ER&#x003b1; and ER&#x003b2; respectively. Cells were maintained at 37&#x000b0;C in a humidified atmosphere of 5% CO2 in air and were cultured in DMEM-F12 (MCF-7 cells) or in RPMI-1640 medium (LnCap cells) supplemented with L-glutamine (2 mM), penicillin (100 U/ml), streptomycin (100 U/ml), and 10% fetal bovine serum (Life Technology, Milan, Italy)</p><p>Negative controls were prepared using tissue lysates, where antigens were previously removed by pre-incubation with specific antibodies (1 hour at room temperature) and subsequently immunoprecipitated with protein A/G -agarose.</p></sec></sec><sec><title>Results</title><sec><title>Histopathological study</title><sec><title>Seminoma</title><p>Morphological analysis of pure seminoma samples (stages I) showed the presence of typical tumoral tissues with uniform populations of large neoplastic cells which were arranged in diffuse sheets separated by thin septae. Extensive leukocyte infiltrations were observed in all samples (Fig <xref ref-type="fig" rid="F1">1A</xref> shows a representative sample).</p><fig position="float" id="F1"><label>Figure 1</label><caption><p><bold>Morphology and immunolocalization of estrogen receptors (ER&#x003b2;1, ER&#x003b2;2) in seminoma, embryonal carcinoma and control testis</bold>. The pictures show representative samples. A, A1, A2: Haematoxylin-Eosin staining. B, B1, B2: ER&#x003b2;1 immunolocalization. C, C1, C2: ER&#x003b2;2 immunodetection. Scale bars = 12,5 m &#x003bc;. L, linfocytes. Lc, Leydig cell. Nc, neoplastic cell. Pc, plurinuclear cell. S, septa. T, seminiferous tubule. Inserts at the bottom right side (B, B1, B2, C, C1, C2): absorption controls. Scale bars = 12,5 m&#x003bc;. Inserts at the top right side (B, B1, C, C1): higher magnification of the pictures. Scale bars = 5 m&#x003bc;.</p></caption><graphic xlink:href="1477-7827-7-56-1"/></fig></sec><sec><title>Embryonal carcinoma</title><p>Tumoral tissues of pure embryonal carcinoma showed nodular areas surrounded by connective tissue. The large neoplastic cells had ill-defined borders, big nuclei, pale cytoplasms and were mainly arranged in glandular pattern. Plurinuclear cells were also present (Fig <xref ref-type="fig" rid="F1">1 A1</xref> shows a representative sample).</p></sec><sec><title>IGCN</title><p>The regions adjacent to seminoma (70% of samples) and to embryonal carcinoma (60% of samples) have shown the presence of seminiferous tubules lacking spermatogenesis, which were identified as intratubular germ cell neoplasia (IGCN), unclassified type. These intratubular lesions were characterized by the basal proliferation of undifferentiated atypical enlarged germ cells, with big nuclei, and by the presence of Sertoli cells in luminal displacement. Cytoplasmic and membranous dark staining have revealed the PLAP immunopositivity in the malignant cells aligned along the basal portion of seminiferous tubules (Fig <xref ref-type="fig" rid="F2">2A, B</xref>), indicating their germ cell origin.</p><fig position="float" id="F2"><label>Figure 2</label><caption><p><bold>PLAP staining and immunolocalization of estrogen receptors (ER&#x003b2;1, ER&#x003b2;2) in intratubular germ cell neoplasia adjacent to seminoma (A) and embryonal carcinoma(B); the pictures show representative samples</bold>. A, B: PLAP staining. A1, B1: ER&#x003b2;1 immunolocalization. A2, B2: ER&#x003b2;2 immunodetection. Ncg, neoplastic germ cell. Sc, Sertoli cell. Scale bars = 5 m&#x003bc;.</p></caption><graphic xlink:href="1477-7827-7-56-2"/></fig></sec></sec><sec><title>Immunohistochemistry</title><p>Immunostainings of all seminoma and embryonal carcinoma specimens revealed an intense nuclear ER&#x003b2;1 and ER&#x003b2;2 immunoreactivity of neoplastic cells while the leukocytes were immunonegative (Fig <xref ref-type="fig" rid="F1">1:B, C, B1, C1</xref>)</p><p>As expected, in control testis sections the cells of tubular and interstitial compartments showed strong exclusively nuclear ER&#x003b2;1 and ER&#x003b2;2 immunostainings (Fig <xref ref-type="fig" rid="F1">1:B2, C2</xref>). ER&#x003b1; signal was totally absent in control and tumoral testes) (Fig <xref ref-type="fig" rid="F3">3A, B, C</xref>).</p><fig position="float" id="F3"><label>Figure 3</label><caption><p><bold>Immunolocalization of ER&#x003b1; in seminoma (A), embryonal carcinoma(B) and control testis (C); the pictures show representative samples</bold>. L, linfocytes. Lc, Leydig cells. Nc, neoplastic cell. T, seminiferous tubules. Scale bars = 12,5 m&#x003bc;.</p></caption><graphic xlink:href="1477-7827-7-56-3"/></fig><p>Table <xref ref-type="table" rid="T1">1</xref> shows the intensity staining scores of tumoral and control samples. Statistical analysis evidenced that ER&#x003b2;1 score of seminomas was higher than ER&#x003b2;1 score of control testes (p &#x0003c; 0.05).</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Immunostaining scores (Allred score) of ER&#x003b2;1 and ER&#x003b2;2 in tumoral and control testes</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center"><bold>Groups</bold></td><td align="center"><bold>ERbeta1</bold></td><td align="center"><bold>ERbeta2</bold></td></tr></thead><tbody><tr><td align="center"><italic>seminoma</italic></td><td></td><td></td></tr><tr><td align="center">Patient 1</td><td align="center">8</td><td align="center">7</td></tr><tr><td align="center">" 2</td><td align="center">6</td><td align="center">5</td></tr><tr><td align="center">" 3</td><td align="center">7</td><td align="center">6</td></tr><tr><td align="center">" 4</td><td align="center">7</td><td align="center">6</td></tr><tr><td align="center">" 5</td><td align="center">7</td><td align="center">6</td></tr><tr><td align="center">" 6</td><td align="center">8</td><td align="center">6</td></tr><tr><td align="center">" 7</td><td align="center">7</td><td align="center">7</td></tr><tr><td align="center">" 8</td><td align="center">8</td><td align="center">5</td></tr><tr><td align="center">" 9</td><td align="center">7</td><td align="center">6</td></tr><tr><td align="center">" 10</td><td align="center">8</td><td align="center">6</td></tr><tr><td align="center"><italic>embryonal carcinoma</italic></td><td></td><td></td></tr><tr><td align="center">Patient 1</td><td align="center">6</td><td align="center">5</td></tr><tr><td align="center">" 2</td><td align="center">6</td><td align="center">5</td></tr><tr><td align="center">" 3</td><td align="center">7</td><td align="center">6</td></tr><tr><td align="center">" 4</td><td align="center">7</td><td align="center">5</td></tr><tr><td align="center">" 5</td><td align="center">7</td><td align="center">6</td></tr><tr><td align="center"><italic>control testis</italic></td><td></td><td></td></tr><tr><td align="center">Patient 1</td><td align="center">6</td><td align="center">5</td></tr><tr><td align="center">" 2</td><td align="center">6</td><td align="center">5</td></tr></tbody></table><table-wrap-foot><p>Immunostained slides scores as follows: Total score= Proportion score+ Intesity score (range 0&#x02013;8)</p></table-wrap-foot></table-wrap><p>In addition, neoplastic cells of intratubular germ cell neoplasia (IGCN), adjacent to seminoma and embryonal carcinoma, revealed a positive ER&#x003b2;1 and ER&#x003b2;2 immunostaining (Fig <xref ref-type="fig" rid="F2">2: A1, A2, B1, B2</xref>) but no ER&#x003b1; immunoreactivity (data not shown).</p><p>All tissues used as positive controls showed a strong ER&#x003b1;/ER&#x003b2;1/ER&#x003b2;2 immunoreactivity (data not shown). Furthermore, negative controls (data not shown) and absorption controls (inserts) were all immunonegative.</p></sec><sec><title>Western blot analysis</title><p>For WB analysis of tumour extracts we have used a single ER&#x003b2; antibody which was tested for this application. This anti-ER&#x003b2; antibody, mapping at the N-terminus region of human native ER&#x003b2;, let us to reveal both the ER&#x003b2; subtypes. In fact, the immunoblots of seminoma and embryonal carcinoma extracts showed a thick ER&#x003b2;1 band at ~59 kDa and a thin ER&#x003b2;2 band ~53 kDa (Fig <xref ref-type="fig" rid="F4">4B</xref>: <italic>lanes 1, 2</italic>). Similar bands were observed in the LnCap cell extract, used as positive control (Fig <xref ref-type="fig" rid="F4">4B</xref>: <italic>lane C</italic>). Conversely, using an antibody against ER&#x003b1;, no protein band has been observed in the immunoblots of tumoral testes (Fig <xref ref-type="fig" rid="F4">4A</xref>: <italic>lanes 1, 2</italic>), while MCF7 cell extract (positive control) showed the classical ~67 kDa band (Fig <xref ref-type="fig" rid="F4">4A</xref>: <italic>lane C</italic>). As expected, control testes showed the ~59 kDa ER&#x003b2;1 band and the ~53 kDa ER&#x003b2;2 band (Fig <xref ref-type="fig" rid="F4">4B</xref>: <italic>lane 3</italic>) but not the ER&#x003b1; band (Fig <xref ref-type="fig" rid="F4">4A</xref>: <italic>lane 3</italic>)All the negative control lanes were unlabelled (data not shown).</p><fig position="float" id="F4"><label>Figure 4</label><caption><p><bold>Immunoblots of estrogen receptors (ER&#x003b1;, ER&#x003b2;1, ER&#x003b2;2) from representative protein extracts of seminoma and embryonal carcinoma</bold>. ER&#x003b1; immunoblot (A): MCF7 cultured cells <italic>(C)</italic>, seminoma <italic>(lane 1</italic>), embryonal carcinoma <italic>(lane 2) </italic>and control testis <italic>(lane 3</italic>). ER&#x003b2;1- ER&#x003b2;2 immunoblot (B): LnCap cultured cells <italic>(C)</italic>, seminoma <italic>(lane 1</italic>), embryonal carcinoma <italic>(lane2) </italic>and control testis <italic>(lane 3</italic>). &#x003b2;-actin serves as a loading control. <italic>Numbers </italic>on the left-hand side correspond to the standard molecular weights <italic>Numbers </italic>on the right-hand side correspond to molecular weights of the detected protein.</p></caption><graphic xlink:href="1477-7827-7-56-4"/></fig></sec></sec><sec><title>Discussion</title><p>Testicular germ cell tumours are joined to cryptorchidism, hypospadias and impaired spermatogenesis in the "testicular dysgenesis syndrome" (TDS), which includes disorders resulting from the impairment of fetal gonadal development [<xref ref-type="bibr" rid="B20">20</xref>]. In normal human testis, fetal gonocytes change into neonatal spermatogonia which mature into viable sperm after puberty. Conversely, testicular germ cell tumours appear to arise from abnormal gonocytes which arrest their differentiation, undergoing a malignant transformation [<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B22">22</xref>].</p><p>Increased estrogen exposure could be an important aetiological factor to promote the TDS disorders and particularly testis cancer [<xref ref-type="bibr" rid="B6">6</xref>], but the related molecular mechanisms remain to be elucidated.</p><p>Estrogen receptors orchestrate both transcriptional and non genomic cellular responses to estrogens. Therefore, they are involved in physiological germ cell differentiation, but, at the same time, they could mediate the estrogen signalling on malignant germ cell proliferation, probably damaging DNA such as reported in breast cancer [<xref ref-type="bibr" rid="B23">23</xref>].</p><p>Estrogen receptor-&#x003b2; mediates physiological estrogen action in somatic and germ cells of normal human testis [<xref ref-type="bibr" rid="B10">10</xref>-<xref ref-type="bibr" rid="B12">12</xref>], but its possible involvement in estrogen-induced carcinogenicity has been also reported. In fact, experimental estrogen exposure of rat testis resulted in oxidative DNA damage via an ER&#x003b2;-mediated process [<xref ref-type="bibr" rid="B24">24</xref>].</p><p>The present work has identified ER&#x003b2;1 and ER&#x003b2;2 in neoplastic cell nuclei of seminoma and embryonal carcinoma, which are the most common testicular germ cell tumours. Agreeing with Saunders's report [<xref ref-type="bibr" rid="B11">11</xref>], a nuclear staining of the two ER&#x003b2; isoforms has been also observed in control germ cells. Western blot analysis of tumour extracts confirmed these findings showing two protein bands consistent with the ER&#x003b2;1 and ER&#x003b2;2 molecular weights.</p><p>Two previous studies detected differentially ER&#x003b2;1 in testicular germ cell tumours. In fact, ER&#x003b2; expression was strong in endoderma sinus tumour and in teratoma [<xref ref-type="bibr" rid="B16">16</xref>] but it was low in seminoma and in embryonal carcinoma [<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B25">25</xref>]. Furthermore, a punctuate cytoplasmic ER&#x003b2; localization has been reported in three seminoma tumoral fragments as well as in seminoma cell line (JKT-1) [<xref ref-type="bibr" rid="B26">26</xref>]. Therefore, previous data are conflictual with respect to our results which have evidenced a remarkable and undoubted ER&#x003b2;1 and ER&#x003b2;2 immunoreactivity in the nuclei of seminoma and embryonal carcinoma cells. These discrepancies could be due to the variability in protein expression of different tumour samples and/or to the use of different antibodies. Despite of previous studies, the present investigation has performed immunohistochemical experiments using primary antibodies which were specific for each of the two ER&#x003b2; isoforms and tested for imminohistochemistry.</p><p>Our data do not support a possible role of the ER&#x003b2; down regulation in testicular tumorigenesis as hypothesized by the previous authors; however, as these results are conflictual, further studies need to confirm them.</p><p>In addition, our work has shown the ER&#x003b2;1 and ER&#x003b2;2 expression in the big neoplastic cells (recognized by PLAP) of IGCN which are considered the pre-invasive precursors of testicular germ cell tumours. In fact, phenotypic similarity of IGCN cells with fetal gonocytes, embryonic stem cells and primordial germ cells [<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B27">27</xref>-<xref ref-type="bibr" rid="B29">29</xref>] suggested that IGCN cells are originated from the arrest of fetal germ cell differentiation followed by malignant transformation. Therefore, our paper has revealed, for the first time, the expression of ER&#x003b2;1 and ER&#x003b2;2 in the early stages of testicular tumorigenesis process. Interestingly, the two ER&#x003b2; isoforms were identified in human fetal gonocytes [<xref ref-type="bibr" rid="B30">30</xref>], but with a clear prevalence of ER&#x003b2;2 on ER&#x003b2;1.</p><p>Previous studies from our laboratory demonstrated aromatase expression in tumoral cells of seminoma and adjacent IGCN [<xref ref-type="bibr" rid="B31">31</xref>], as well as in embryonal carcinoma [unpublished data], indicating a local estrogen production. In the current study, seminoma and embryonal carcinoma cells, expressing ER&#x003b2;1 and ER&#x003b2;2 but not ER&#x003b1;, have shown an ER pattern similar to that one of normal testicular cells. A high ER&#x003b2;1 immunoreactivity of seminoma cells has been detected, but this new finding needs to be confirmed in a larger size of sample set, before speculating its involvement in the autocrine/paracrine estrogen action promoting testicular germ cell malignancies.</p><p>Conversely, our recent paper evidenced an altered ER expression pattern in two human Leydig cell tumours, suggesting the possible contribute of the unexpected ER&#x003b1; presence to the tumour cell growth and progression [<xref ref-type="bibr" rid="B32">32</xref>]. A recent work [<xref ref-type="bibr" rid="B33">33</xref>] suggested that estrogens could contribute to human testicular germ cell cancer proliferation by a rapid activation of ERK1/2 and PKA through a non classical membrane ER. Therefore, further studies will be necessary to expand the knowledge of estrogen signalling involved in testicular tumorigenesis.</p></sec><sec><title>Conclusion</title><p>The present study has demonstrated the expression of ER&#x003b2;1 and ER&#x003b2;2 in seminoma and embryonal carcinoma cells, as well as in neoplastic cells of their pre-invasive precursor, IGCN. Therefore, our findings suggest that the two ER&#x003b2; subtypes can mediate estrogen action in both early and late neoplastic testicular germ cells, not confirming a possible suppressive role of ER&#x003b2; on male gonadal cell proliferation, as previously hypothesized.</p></sec><sec><title>Competing interests</title><p>This work was supported by MURST and Ex 60% 2008, and PRIN 2008.</p></sec><sec><title>Authors' contributions</title><p>VR: the author responsible for performing the immunohistochemical expriments and participating in the analysis and interpretation of data.</p><p>FR: the author responsible for histoplathological diagnosis.</p><p>FG: the author responsible for performing Western blot analysis.</p><p>AF: the author responsible for sample collection.</p><p>SA: the author responsible for a critical revision of the manuscript.</p><p>AC: the author responsible for conception, design, analysis and interpretation of data as well as of drafting manuscript.</p><p>All authors read and approved the final manuscript</p></sec></body><back><ack><sec><title>Acknowledgements</title><p>The authors thank prof. Antonietta Martire for the English reviewing of this manuscript.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McGlynn</surname><given-names>KA</given-names></name><name><surname>Devesa</surname><given-names>SS</given-names></name><name><surname>Sigurdson</surname><given-names>AJ</given-names></name><name><surname>Brown</surname><given-names>LM</given-names></name><name><surname>Tsao</surname><given-names>L</given-names></name><name><surname>Tarone</surname><given-names>RE</given-names></name></person-group><article-title>Trends in the incidence of testicular germ cell tumors in the United States</article-title><source>Cancer</source><year>2003</year><volume>97</volume><fpage>63</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">12491506</pub-id><pub-id pub-id-type="doi">10.1002/cncr.11054</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rajpert-De Meyts</surname><given-names>E</given-names></name></person-group><article-title>Recent advances and future directions in research on testicular germ cell cancer</article-title><source>Int J Androl</source><year>2007</year><volume>30</volume><fpage>192</fpage><lpage>197</lpage><pub-id pub-id-type="pmid">17705803</pub-id><pub-id pub-id-type="doi">10.1111/j.1365-2605.2007.00810.x</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Depue</surname><given-names>RH</given-names></name><name><surname>Pike</surname><given-names>MC</given-names></name><name><surname>Henderson</surname><given-names>BE</given-names></name></person-group><article-title>Estrogen exposure during gestation and risk of testicular cancer</article-title><source>J Natl Cancer Inst </source><year>1983</year><volume>71</volume><fpage>1151</fpage><lpage>1155</lpage><pub-id pub-id-type="pmid">6140323</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weir</surname><given-names>HK</given-names></name><name><surname>Marrett</surname><given-names>LD</given-names></name><name><surname>Kreiger</surname><given-names>N</given-names></name><name><surname>Darlington</surname><given-names>GA</given-names></name><name><surname>Sugar</surname><given-names>L</given-names></name></person-group><article-title>Pre-natal and peri-natal exposure and risk of testicular germ cell cancer</article-title><source>Int J Cancer</source><year>2000</year><volume>87</volume><fpage>438</fpage><lpage>443</lpage><pub-id pub-id-type="pmid">10897052</pub-id><pub-id pub-id-type="doi">10.1002/1097-0215(20000801)87:3&#x0003c;438::AID-IJC20&#x0003e;3.0.CO;2-1</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Strohsnitter</surname><given-names>WC</given-names></name><name><surname>Noller</surname><given-names>KL</given-names></name><name><surname>Hoover</surname><given-names>RN</given-names></name><name><surname>Robboy</surname><given-names>SJ</given-names></name><name><surname>Palmer</surname><given-names>JR</given-names></name><name><surname>Titus-Ernstoff</surname><given-names>L</given-names></name><name><surname>Kaufman</surname><given-names>RH</given-names></name><name><surname>Adam</surname><given-names>E</given-names></name><name><surname>Herbst</surname><given-names>AL</given-names></name><name><surname>Hatch</surname><given-names>EE</given-names></name></person-group><article-title>Cancer risk in men exposed in utero to diethylstilbestrol</article-title><source>J Natl Cancer Inst </source><year>2001</year><volume>93</volume><fpage>545</fpage><lpage>551</lpage><pub-id pub-id-type="pmid">11287449</pub-id><pub-id pub-id-type="doi">10.1093/jnci/93.7.545</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sharpe</surname><given-names>RM</given-names></name></person-group><article-title>The 'oestrogen hypothesis'- where do we stand now?</article-title><source>Int J Androl</source><year>2003</year><volume>26</volume><fpage>2</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">12534932</pub-id><pub-id pub-id-type="doi">10.1046/j.1365-2605.2003.00367.x</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Blobel</surname><given-names>GA</given-names></name><name><surname>Orkin</surname><given-names>SH</given-names></name></person-group><article-title>Estrogen induced apoptosis by inhibition of the erythroid transcription factor GATA-1</article-title><source>Mol Cell Biol</source><year>1996</year><volume>16</volume><fpage>1687</fpage><lpage>1694</lpage><pub-id pub-id-type="pmid">8657144</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mabuchi</surname><given-names>S</given-names></name><name><surname>Ohmichi</surname><given-names>M</given-names></name><name><surname>Kimura</surname><given-names>A</given-names></name><name><surname>Nishio</surname><given-names>Y</given-names></name><name><surname>Arimoto-Ishida</surname><given-names>E</given-names></name><name><surname>Yada-Hashimoto</surname><given-names>N</given-names></name><name><surname>Tasaka</surname><given-names>K</given-names></name><name><surname>Murata</surname><given-names>Y</given-names></name></person-group><article-title>Estrogen inhibits paclitaxel induced apoptosis via the phosphorylation of apoptosis signal regulating kinase 1 in human ovary cancer cell lines</article-title><source>Endocrinology</source><year>2004</year><volume>145</volume><fpage>49</fpage><lpage>58</lpage><pub-id pub-id-type="pmid">14500571</pub-id><pub-id pub-id-type="doi">10.1210/en.2003-0792</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moggs</surname><given-names>JG</given-names></name><name><surname>Orphanides</surname><given-names>G</given-names></name></person-group><article-title>Estrogen receptors: orchestrators of pleiotropic cellular responses</article-title><source>EMBO Rep</source><year>2001</year><volume>2</volume><fpage>775</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">11559590</pub-id><pub-id pub-id-type="doi">10.1093/embo-reports/kve185</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saunders</surname><given-names>PT</given-names></name><name><surname>Sharpe</surname><given-names>RM</given-names></name><name><surname>Williams</surname><given-names>K</given-names></name><name><surname>Macpherson</surname><given-names>S</given-names></name><name><surname>Urquart</surname><given-names>H</given-names></name><name><surname>Irvine</surname><given-names>DS</given-names></name><name><surname>Millar</surname><given-names>MR</given-names></name></person-group><article-title>Differential expression of oestrogen receptor &#x003b1; and &#x003b2; proteins in the testes and male reproductive system of human and non-human primates</article-title><source>Mol Hum Reprod</source><year>2001</year><volume>7</volume><fpage>227</fpage><lpage>236</lpage><pub-id pub-id-type="pmid">11228242</pub-id><pub-id pub-id-type="doi">10.1093/molehr/7.3.227</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saunders</surname><given-names>PTK</given-names></name><name><surname>Millar</surname><given-names>MR</given-names></name><name><surname>Macpherson</surname><given-names>S</given-names></name><name><surname>Irvine</surname><given-names>DS</given-names></name><name><surname>Groome</surname><given-names>NP</given-names></name><name><surname>Evans</surname><given-names>LR</given-names></name><name><surname>Sharpe</surname><given-names>RM</given-names></name><name><surname>Scobie</surname><given-names>GA</given-names></name></person-group><article-title>ER&#x003b2;1 and ER&#x003b2;2 splice variant (ER&#x003b2;cx/&#x003b2;2) are expressed in distinct cell populations in the adult human testis</article-title><source>J Clin Endocrinol Metab</source><year>2002</year><volume>87</volume><fpage>2706</fpage><lpage>2715</lpage><pub-id pub-id-type="pmid">12050238</pub-id><pub-id pub-id-type="doi">10.1210/jc.87.6.2706</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aschim</surname><given-names>EL</given-names></name><name><surname>Saether</surname><given-names>T</given-names></name><name><surname>Wiger</surname><given-names>R</given-names></name><name><surname>Grotmol</surname><given-names>T</given-names></name><name><surname>Haugen</surname><given-names>TB</given-names></name></person-group><article-title>Differential distribution of splice variants of estrogen receptor beta in human testicular cells suggests specific functions in spermatogenesis</article-title><source>J Steroid Biochem Mol Biol</source><year>2004</year><volume>92</volume><fpage>97</fpage><lpage>106</lpage><pub-id pub-id-type="pmid">15544935</pub-id><pub-id pub-id-type="doi">10.1016/j.jsbmb.2004.05.008</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Leung</surname><given-names>YK</given-names></name><name><surname>Mak</surname><given-names>P</given-names></name><name><surname>Hassan</surname><given-names>S</given-names></name><name><surname>Ho</surname><given-names>SM</given-names></name></person-group><article-title>Estrogen receptor (ER)-beta isoforms: a key to understanding ER-beta signaling</article-title><source>Proc Natl Acad Sci USA</source><year>2006</year><volume>103</volume><fpage>13162</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">16938840</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0605676103</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ogawa</surname><given-names>S</given-names></name><name><surname>Inoue</surname><given-names>S</given-names></name><name><surname>Watanabe</surname><given-names>T</given-names></name><name><surname>Orimo</surname><given-names>A</given-names></name><name><surname>Hosoi</surname><given-names>T</given-names></name><name><surname>Ouchi</surname><given-names>Y</given-names></name><name><surname>Muramatsu</surname><given-names>M</given-names></name></person-group><article-title>Molecular cloning and characterization of human estrogen receptor betacx: a potential inhibitor of estrogen action in human</article-title><source>Nucleic Acid Res</source><year>1998</year><volume>26</volume><fpage>3505</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">9671811</pub-id><pub-id pub-id-type="doi">10.1093/nar/26.15.3505</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Green</surname><given-names>CA</given-names></name><name><surname>Peter</surname><given-names>MB</given-names></name><name><surname>Speirs</surname><given-names>V</given-names></name><name><surname>Shaaban</surname><given-names>AM</given-names></name></person-group><article-title>The potential role of ER&#x003b2; isoforms in the cinical management of breast cancer</article-title><source>Histopathology</source><year>2008</year><volume>53</volume><fpage>374</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">18312354</pub-id><pub-id pub-id-type="doi">10.1111/j.1365-2559.2008.02968.x</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pais</surname><given-names>V</given-names></name><name><surname>Leav</surname><given-names>I</given-names></name><name><surname>Lau</surname><given-names>KM</given-names></name><name><surname>Jiang</surname><given-names>Z</given-names></name><name><surname>Ho</surname><given-names>SM</given-names></name></person-group><article-title>Estrogen receptor-beta expression in human testicular germ cell tumors</article-title><source>Clin Cancer Res</source><year>2003</year><volume>9</volume><fpage>4475</fpage><lpage>4482</lpage><pub-id pub-id-type="pmid">14555521</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Allred</surname><given-names>DC</given-names></name><name><surname>Harvey</surname><given-names>JM</given-names></name><name><surname>Berardo</surname><given-names>M</given-names></name><name><surname>Clark</surname><given-names>GM</given-names></name></person-group><article-title>Prognostic and predictive factors in breast cancer by immunohistochemical analysis</article-title><source>Modern Pathology</source><year>1998</year><volume>11</volume><fpage>155</fpage><lpage>168</lpage><pub-id pub-id-type="pmid">9504686</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ikeda</surname><given-names>K</given-names></name><name><surname>Monden</surname><given-names>T</given-names></name><name><surname>Kanoh</surname><given-names>T</given-names></name><name><surname>Tsujie</surname><given-names>M</given-names></name><name><surname>Izawa</surname><given-names>H</given-names></name><name><surname>Haba</surname><given-names>A</given-names></name><name><surname>Ohnishi</surname><given-names>T</given-names></name><name><surname>Sekimoto</surname><given-names>M</given-names></name><name><surname>Tomita</surname><given-names>N</given-names></name><name><surname>Shiozaki</surname><given-names>H</given-names></name><name><surname>Monden</surname><given-names>M</given-names></name></person-group><article-title>Extraction and analysis of diagnostically useful proteins from formalin-fixed, paraffin-embedded tissue sections</article-title><source>J Histochem Cytochem </source><year>1998</year><volume>46</volume><fpage>397</fpage><lpage>403</lpage><pub-id pub-id-type="pmid">9487122</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bradford</surname><given-names>MM</given-names></name></person-group><article-title>A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding</article-title><source>Analytical Biochemistry</source><year>1976</year><volume>72</volume><fpage>248</fpage><lpage>254</lpage><pub-id pub-id-type="pmid">942051</pub-id><pub-id pub-id-type="doi">10.1016/0003-2697(76)90527-3</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Skakkebaek</surname><given-names>NE</given-names></name><name><surname>Rajpert-De Meyts</surname><given-names>E</given-names></name><name><surname>J&#x000f8;rgensen</surname><given-names>N</given-names></name><name><surname>Main</surname><given-names>KM</given-names></name><name><surname>Leffers</surname><given-names>H</given-names></name><name><surname>Andersson</surname><given-names>AM</given-names></name><name><surname>Juul</surname><given-names>A</given-names></name><name><surname>Jensen</surname><given-names>TK</given-names></name><name><surname>Toppari</surname><given-names>J</given-names></name></person-group><article-title>Testicular cancer trends as 'whistle blowers' of testicular developmental problems in populations</article-title><source>Int J Androl</source><year>2007</year><volume>30</volume><fpage>198</fpage><lpage>204</lpage><pub-id pub-id-type="pmid">17705804</pub-id><pub-id pub-id-type="doi">10.1111/j.1365-2605.2007.00776.x</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Looijenga</surname><given-names>LH</given-names></name><name><surname>de Munnik</surname><given-names>H</given-names></name><name><surname>Osterhuis</surname><given-names>JW</given-names></name></person-group><article-title>A molecular model for the development of germ cell cancer</article-title><source>Int J Cancer</source><year>1999</year><volume>83</volume><fpage>809</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">10597200</pub-id><pub-id pub-id-type="doi">10.1002/(SICI)1097-0215(19991210)83:6&#x0003c;809::AID-IJC20&#x0003e;3.0.CO;2-0</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rajpert-de Meyts</surname><given-names>E</given-names></name><name><surname>Hoei-Hansen</surname><given-names>CE</given-names></name></person-group><article-title>From gonocytes to testicular cancer: the role of impaired gonadal development</article-title><source>Ann N Y Acad Sci</source><year>2007</year><volume>1120</volume><fpage>168</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">18184914</pub-id><pub-id pub-id-type="doi">10.1196/annals.1411.013</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mobley</surname><given-names>JA</given-names></name><name><surname>Brueggemeier</surname><given-names>RW</given-names></name></person-group><article-title>Estrogen receptor-mediated regulation of oxidative stress and DNA damage in breast cancer</article-title><source>Carcinogenesis</source><year>2004</year><volume>25</volume><fpage>3</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">14514655</pub-id><pub-id pub-id-type="doi">10.1093/carcin/bgg175</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wellejus</surname><given-names>A</given-names></name><name><surname>Loft</surname><given-names>S</given-names></name></person-group><article-title>Receptor-mediated ethinylestradiol-induced oxidative DNA damage in rat testicular cells</article-title><source>FASEB J</source><year>2002</year><volume>16</volume><fpage>195</fpage><lpage>201</lpage><pub-id pub-id-type="pmid">11818367</pub-id><pub-id pub-id-type="doi">10.1096/fj.01-0385com</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hirvonen-Santti</surname><given-names>SJ</given-names></name><name><surname>Rannikko</surname><given-names>A</given-names></name><name><surname>Santti</surname><given-names>H</given-names></name><name><surname>Savolainen</surname><given-names>S</given-names></name><name><surname>Nyberg</surname><given-names>M</given-names></name><name><surname>J&#x000e4;nne</surname><given-names>OA</given-names></name><name><surname>Palvimo</surname><given-names>JJ</given-names></name></person-group><article-title>Down-regulation of estrogen receptor beta and transcriptional coregulator SNURF/RNF4 in testicular germ cell cancer</article-title><source>Eur Urol</source><year>2003</year><volume>44</volume><fpage>742</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">14644130</pub-id><pub-id pub-id-type="doi">10.1016/S0302-2838(03)00382-8</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roger</surname><given-names>C</given-names></name><name><surname>Lambard</surname><given-names>S</given-names></name><name><surname>Bouskine</surname><given-names>A</given-names></name><name><surname>Mograbi</surname><given-names>B</given-names></name><name><surname>Chevallier</surname><given-names>D</given-names></name><name><surname>Nebout</surname><given-names>M</given-names></name><name><surname>Pointis</surname><given-names>G</given-names></name><name><surname>Carreau</surname><given-names>S</given-names></name><name><surname>Fenichel</surname><given-names>P</given-names></name></person-group><article-title>Estrogen-induced growth inhibition of human seminoma cells expressing estrogen receptor beta and aromatase</article-title><source>J Mol Endocrinol</source><year>2005</year><volume>35</volume><fpage>191</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">16087732</pub-id><pub-id pub-id-type="doi">10.1677/jme.1.01704</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Skakkebaek</surname><given-names>NE</given-names></name><name><surname>Berthelsen</surname><given-names>JG</given-names></name><name><surname>Giwercman</surname><given-names>A</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>J</given-names></name></person-group><article-title>Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma</article-title><source>Int J Androl</source><year>1987</year><volume>10</volume><fpage>19</fpage><lpage>28</lpage><pub-id pub-id-type="pmid">3034791</pub-id><pub-id pub-id-type="doi">10.1111/j.1365-2605.1987.tb00161.x</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Almstrup</surname><given-names>K</given-names></name><name><surname>Hoei-Hansen</surname><given-names>CE</given-names></name><name><surname>Wirkner</surname><given-names>U</given-names></name><name><surname>Blake</surname><given-names>J</given-names></name><name><surname>Schwager</surname><given-names>C</given-names></name><name><surname>Ansorge</surname><given-names>W</given-names></name><name><surname>Nielsen</surname><given-names>JE</given-names></name><name><surname>Skakkebaek</surname><given-names>NE</given-names></name><name><surname>Rajpert-De Meyts</surname><given-names>E</given-names></name><name><surname>Leffers</surname><given-names>H</given-names></name></person-group><article-title>Embryonic stem cell-like features of testicular carcinoma in situ revealed by genome-wide gene expression profiling</article-title><source>Cancer Res</source><year>2004</year><volume>64</volume><fpage>4736</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">15256440</pub-id><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-04-0679</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Almstrup</surname><given-names>K</given-names></name><name><surname>Ottesen</surname><given-names>AM</given-names></name><name><surname>Sonne</surname><given-names>SB</given-names></name><name><surname>Hoei-Hansen</surname><given-names>CE</given-names></name><name><surname>Leffers</surname><given-names>H</given-names></name><name><surname>Rajpert-De Meyts</surname><given-names>E</given-names></name><name><surname>Skakkebaek</surname><given-names>NE</given-names></name></person-group><article-title>Genomic and gene expression signature of the pre-invasive testicular carcinoma in situ</article-title><source>Cell Tissue Res</source><year>2005</year><volume>322</volume><fpage>159</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">15846514</pub-id><pub-id pub-id-type="doi">10.1007/s00441-005-1084-x</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gaskell</surname><given-names>TL</given-names></name><name><surname>Robinson</surname><given-names>LLL</given-names></name><name><surname>Groome</surname><given-names>NP</given-names></name><name><surname>Anderson</surname><given-names>RA</given-names></name><name><surname>Saunders</surname><given-names>PTK</given-names></name></person-group><article-title>Differential expression of two estrogen receptor &#x003b2; isoforms in the human fetal testis during the second trimester of pregnancy</article-title><source>J Clin Endocrinol Metab</source><year>2003</year><volume>88</volume><fpage>424</fpage><lpage>432</lpage><pub-id pub-id-type="pmid">12519886</pub-id><pub-id pub-id-type="doi">10.1210/jc.2002-020811</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rago</surname><given-names>V</given-names></name><name><surname>Romeo</surname><given-names>F</given-names></name><name><surname>Aquila</surname><given-names>S</given-names></name><name><surname>Montanaro</surname><given-names>D</given-names></name><name><surname>And&#x000f2;</surname><given-names>S</given-names></name><name><surname>Carpino</surname><given-names>A</given-names></name></person-group><article-title>Cytochrome P450 aromatase expression in human seminoma</article-title><source>Reprod Biol Endocrinol</source><year>2005</year><volume>3</volume><fpage>72</fpage><pub-id pub-id-type="pmid">16372909</pub-id><pub-id pub-id-type="doi">10.1186/1477-7827-3-72</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carpino</surname><given-names>A</given-names></name><name><surname>Rago</surname><given-names>V</given-names></name><name><surname>Pezzi</surname><given-names>V</given-names></name><name><surname>Carani</surname><given-names>C</given-names></name><name><surname>And&#x000f2;</surname><given-names>S</given-names></name></person-group><article-title>Detection of aromatase and estrogen receptors (ERalpha, ERbeta1, ERbeta2) in human Leydig cell tumor</article-title><source>Eur J Endocrinol</source><year>2007</year><volume>157</volume><fpage>239</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">17656605</pub-id><pub-id pub-id-type="doi">10.1530/EJE-07-0029</pub-id></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bouskine</surname><given-names>A</given-names></name><name><surname>Nebout</surname><given-names>M</given-names></name><name><surname>Mograbi</surname><given-names>B</given-names></name><name><surname>Br&#x000fc;cker-Davis</surname><given-names>F</given-names></name><name><surname>Roger</surname><given-names>C</given-names></name><name><surname>Fenichel</surname><given-names>P</given-names></name></person-group><article-title>Estrogens promote human testicular germ cell cancer through a membrane-mediated activation of extracellular regulated kinase and protein kinase A</article-title><source>Endocrinology</source><year>2008</year><volume>149</volume><fpage>565</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">18039775</pub-id><pub-id pub-id-type="doi">10.1210/en.2007-1318</pub-id></citation></ref></ref-list></back></article> 